Voyager Therapeutics (VYGR) EBT Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 47.54% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 12.01% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 20.92% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67% |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - | -30.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.53% |
| Dec 31, 2025 | -5.11% |
| Sep 30, 2025 | -52.95% |
| Jun 30, 2025 | -20.46% |
| Mar 31, 2025 | -13.27% |
| Dec 31, 2024 | -105.68% |
| Sep 30, 2024 | 28.88% |
| Jun 30, 2024 | 29.22% |
| Mar 31, 2024 | 23.79% |
| Dec 31, 2023 | 64.11% |
| Sep 30, 2023 | -32.15% |
| Jun 30, 2023 | -36.89% |
| Mar 31, 2023 | 94.15% |
| Dec 31, 2022 | -23.37% |
| Sep 30, 2022 | 46.97% |
| Jun 30, 2022 | -54.83% |
| Mar 31, 2022 | 7.77% |
| Dec 31, 2021 | 30.54% |
| Sep 30, 2021 | -7.24% |
| Jun 30, 2021 | -3.77% |
| Mar 31, 2021 | -8.34% |
| Dec 31, 2020 | -26.08% |
| Sep 30, 2020 | 77.91% |
| Jun 30, 2020 | 22.68% |
| Mar 31, 2020 | -11.60% |
| Dec 31, 2019 | 4.24% |
| Sep 30, 2019 | -17.29% |
| Jun 30, 2019 | 47.28% |
| Mar 31, 2019 | -55.77% |
| Dec 31, 2018 | -45.71% |
| Sep 30, 2018 | -73.02% |
| Jun 30, 2018 | -88.36% |
| Mar 31, 2018 | -11.31% |
| Dec 31, 2017 | -36.00% |
| Sep 30, 2017 | -79.97% |